Vendor source

Reviewed 17 Jun 2026

Completeness Strong (64%)

GadoBoost AI virtually enhances contrast uptake in T1-weighted 3D brain MRI scans and automatically detects contrast-enhancing lesions. It is particularly designed for scenarios where subtle findings need to be identified, such as follow-up examinations of patients with cancers that commonly metastasize to the brain. By increasing the conspicuity of subtle enhancing findings and supporting radiologists with automated detection, GadoBoost AI aims to improve confidence during routine assessment of potentially negative examinations.

No papers to support — we monitor for new evidence.

GadoBoost thumbnail 1
GadoBoost thumbnail 2

Key Features

  • MRI image enhancement
  • Nodule detection

General Information

Product name

GadoBoost

Modality

MR

Main task

Detection

Subspeciality

Neuro

Disease targeted

Not specified

Regulatory Information

CE Certification

Pathway:

MDR

Class:

Class IIa

Verified by Health AI Register

Other certifications

Not specified

Technical Specifications

Patient population age

Adult

Input

3D T1 non-contrast, 3D T1 contrast

Input format

DICOM

Output

AI enhanced series, AI enhanced series with 3D lesion markers, report

Output format

DICOM

Integration

Integration in standard reading environment (PACS)

Deployment

Hybrid solution

Trigger for analysis

On demand, triggered by a user through e.g. a button click, image upload

Processing time

1 - 10 minutes

Population

Not specified

Market Presence

On market since

10-2025

AI Platforms

Resellers

Not specified

Countries present

Not specified

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

Pay-per-use, Subscription

Based on

Number of analyses

Source: Vendor | First published: Jun 17, 2026 | Last updated: Jun 17, 2026

GadoBoost - relios.vision GmbH